Samsara BioCapital, L.P. 13D and 13G filings for Syros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-26 5:19 pm Purchase | 2023-12-21 | 13D | Syros Pharmaceuticals, Inc. SYRS | Samsara BioCapital, L.P. | 2,515,523 9.500% | 909,977 (+56.68%) | Filing |
| 2023-10-20 4:15 pm Purchase | 2023-01-15 | 13D | Syros Pharmaceuticals, Inc. SYRS | Samsara BioCapital, L.P. | 1,605,546 7.500% | 1,605,546 (New Position) | Filing |